Articles
24 September 2026
From pilgrimage to re-rooting: What does integration actually ask of us?
The World Ayahuasca Forum (WAF) took place in Girona, Catalonia, from 11–13 September 2026, bringing together Indigenous wisdom keepers, ayahuasqueros, padrinhos, medicine makers, curanderos, pajés, advocates, conservationists, researchers, practitioners, artists, investors, policymakers, lawyers, and many others working across the global ayahuasca field. “Ayahuasca” is itself an umbrella term and only one name among many for […]
10 September 2026
What is psychedelic intervision, and why do psychedelic practitioners need it?
In a field where most practitioners work alone, unregulated, and with clients who are in a substantial and suggestible altered state of consciousness, psychedelic intervision, or ongoing peer-to-peer reflection, is closer to essential infrastructure than a simple nice-to-have. Ultimately, however sound one’s own therapeutic perspective, framework or positionality, neither you nor your clients may be […]
3 September 2026
Neurodivergent clients and psychedelics: what competent support actually requires
Neurodivergent people are already in psychedelic spaces. Diagnosed or not, disclosed or not – they are already showing up to ceremonies, clinical trials, and coaching sessions. The question is whether the space is ready for them. Guest contributions from Dr. WaiFung Tsang and Nadia Violet Erlam Foreword By Dr. WaiFung Tsang Neurodiversity should not be […]
26 August 2026
What clinical studies can, and can’t, tell us about psychedelic practice: Therapeutic misconception, clinical equipoise and why promising results still need real-world standards
I spend much of my working life inside psychedelic clinical studies. From the outside, a psychedelic study may look, at this point in time, given the 200+ clinical trials globally and an even greater number of experimental medicine studies, a relatively simple and easy thing to deliver and do. A person receives a drug, has […]
18 August 2026
Living with your cycle, not against it: What psychedelics, hormones and the female cycle have to do with each other
The morning of the ceremony, I wake with abdominal pain. I am on day 38 of my cycle. My period normally arrives around day 30 or 31, but something has been shifting in recent months. My cycles are getting longer, and my period keeps arriving later. A few hours later, I am lying on a […]
6 August 2026
The relational container: Structuring couples work with psychedelic support
The couple in the room More couples are seeking psychedelic support together, and they arrive through different doors. Some come after one partner’s individual journey shifted something between them. Some arrive carrying a specific wound, a break in trust and agreement, a loss, and ask for repair before anything else. Many begin with conflict work […]
23 July 2026
Beyond the drug: Lessons from therapists on what shapes outcomes in psychedelic-assisted therapy
FOREWORD Psychedelic research is often framed around a simple question: do these treatments work? Over the past decade, that question has generated an exciting body of research. But as psychedelic-assisted therapy moves closer to clinical implementation, I think another question is becoming just as important: what actually determines whether someone benefits? In my PhD research, […]
16 July 2026
Honouring the mystical: How to integrate entities and mystical-type experiences
Some of the most important experiences a client brings back are the ones no one taught their practitioner how to hold. A being that seemed to communicate, sense of having touched something sacred, the conviction that they briefly saw how everything connects. In almost every conversation we have about experiences like these, the same thing comes up: the person was left alone with the part that mattered most.
7 July 2026
PsyStandard and Drug Science announce collaboration on European psychedelic practitioner verification framework
PsyStandard, a Pink Elephant Company, and Drug Science announce a co-design partnership to develop the clinical and ethical foundations of PsyStandard’s European practitioner verification framework. The partnership addresses a structural gap in how practitioner quality is assessed in psychedelic practice. People seeking support — whether through clinical therapy, retreat settings, or integration coaching — currently […]
2 July 2026
Any good therapist can do this. Can’t they? Why psychedelic integration is not just talk therapy
The assumption is widespread and, on the surface, reasonable: a psychedelic experience has already happened, the person sitting across from you needs support working through what came up, and you are a trained therapist who knows how to hold difficult material. So what exactly is the problem? This article is about what integration work specifically […]
29 June 2026
PsyStandard and Blossom announce collaboration on European psychedelic practitioner verification framework
PsyStandard, a Pink Elephant Company, and Blossom announce a strategic collaboration to develop a comprehensive practitioner verification framework for European psychedelic practise. The partnership addresses a critical infrastructure gap: people seeking psychedelic care — whether through clinical therapy, retreat settings, or integration coaching — currently lack reliable methods to assess practitioner competence. While credentials verify […]
22 June 2026
Therapist, facilitator, coach: Defining your role and relational frame in psychedelic work
Foreword by Laurin Angermeier I have sat with many people over the years who had done everything right. They had seen a clinical psychotherapist, often for years. They had followed a protocol, worked within a clinical setting, shown up consistently and in good faith. And yet something did not move. The change they came looking […]
5 June 2026
Can psilocybin save your relationship? An expert’s insight into psychedelic couples therapy
Sarah Tilley explains how psilocybin therapy may hold the key to healthier relationships.
4 June 2026
Ethical is not enough. Excellent is not enough. Why psychedelic care needs both, and what we built to find it.
Something I have observed consistently, in my own practice and in conversations across the field: the practitioners who cause harm are rarely the ones who set out to. Most of them believed in what they were doing. Many had genuine gifts, real relational presence, a capacity to sit with difficulty. What they lacked was the […]
3 June 2026
How to choose a psychedelic facilitator: 8 questions to ask
Foreword by Laurin Angermeier · Neuroscience & Clinical Strategy Advisor, States of Mind When I talk to someone who is considering their first facilitated psychedelic experience, the question I hear most often is not “which substance?” or “which retreat?” It is: “How do I know if someone is actually good at this?” That question is […]
